ReviewCancers2026

A New Paradigm for Pediatric AML: Improving the Pipeline for Treatments Targeting Cytogenetic and Molecular Alterations.

Camila Ayerbe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.